WHO-GMP Certified Commercial Pack · Product Code: AKP-006-LIQ
Artemether Injection 40 mg / ml
Formulation Overview: Ready-to-inject lipid-soluble artemisinin derivative (40 mg / ml) in USP Type I glass ampoules delivering rapid intra-erythrocytic schizonticidal action for ICU and rural malaria clinics. Formulated with Artemether 40 mg / ml (40 mg / ml) in Sterile Intramuscular Liquid Injection Ampoule dosage form under Antimalarials Medication, manufactured to IP / BP / USP Compendial standards and supplied in 6 x 1 ml Amber / Clear USP Type I Glass Ampoules with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-006-LIQ |
|---|---|
| Catalog Reference | AKP-006-LIQ · SN 6-Liq |
| Therapeutic Sector | Antimalarials Medication |
| Dosage Form | Sterile Intramuscular Liquid Injection Ampoule |
| Active Ingredient | Artemether 40 mg / ml |
| Strength / Purity | 40 mg / ml |
| Clinical Indication | Severe chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria emergency care |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 6 x 1 ml Amber / Clear USP Type I Glass Ampoules |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C, protect from light & do not freeze |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |